spacer
home > ict > winter 2020 > removing barriers for paediatric patients in clinical trials
PUBLICATIONS
International Clinical Trials

Removing Barriers for Paediatric Patients in Clinical Trials




Designed by Katemangostar / Freepik

As scientific breakthroughs in healthcare advance, our ability to discover and diagnose diseases earlier has renewed the need for paediatric research. However, there has been a growing tension between the need to license medication, strict regulations, and the recognised unprofitability of conducting trials in the paediatric population.

A major consideration in paediatric trials involves balancing the rights, safety, and well-being of children while meeting financial requirements to enable the production of safe, licensed medication. Perceived challenges in striking this balance may be a deterrent for some pharmaceutical companies.

Some of the key challenges include a lack of paediatric trials, leading to fewer licensed medications for children, misconceptions and mistrust participants may have in research, which may hinder participation in clinical trials, and how the industry may influence paediatric research through community education, with a hope that children will not be left behind as healthcare research continues to progress.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
About the author


Evelyn Kamau is the Global Head of Nursing at the MRN and has over 20 years’ nursing experience. Evelyn has worked in critical care, haemodialysis and neurology centres both in the UK and her native country Kenya. Evelyn has been a lecturer for both undergraduate and postgraduate nursing students, a position that led her to the neurosurgery department at Cambridge University, where she was involved in pioneering research in the understanding and management of disorders of consciousness. She left Cambridge University to manage community-based trials at the MRN in 2016.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients

Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients. Following the dynamic growth of the drug delivery devices market, as a world leader, Nemera is thrilled to extend its manufacturing capabilities in Poland.
More info >>

White Papers

The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products

Biopharma Group

Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement